Massimo Libra
University of Catania(IT)
Publications by Year
Research Areas
PI3K/AKT/mTOR signaling in cancer, Melanoma and MAPK Pathways, Nutritional Studies and Diet, MicroRNA in disease regulation, Chronic Lymphocytic Leukemia Research
Most-Cited Works
- → Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance(2006)2,275 cited
- → Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium(2018)869 cited
- → Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging(2011)695 cited
- → Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance(2006)661 cited
- → Cutaneous melanoma: From pathogenesis to therapy (Review)(2018)588 cited
- → Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health(2011)575 cited
- → Gut Microbiota and Cancer: From Pathogenesis to Therapy(2019)563 cited
- → GSK-3 as potential target for therapeutic intervention in cancer(2014)493 cited
- → Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia(2008)395 cited
- → Akt inhibitors in cancer treatment: The long journey from drug discovery to clinical use (Review)(2015)362 cited